IBM study, with funding from Myositis UK:
In this exploratory study, comparison of patients with IBM with and without anti-cN-1A autoantibody reactivity identified differences in their mortality risk, clinical characteristics and histopathological findings. The largest study of its kind has demonstrated that anti-cN-1A antibody testing may, and over and above its diagnostic value, be clinically useful to define distinct IBM subtypes.
Just been diagnosed 
Dermatomyositis 
New here! 
How do you get a firm Mysiotis diagnosis? What scans will show affects on muscles? 
